2-aminopyrimidine derivatives as raf kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/04 (2006.01) A61K 31/155 (2006.01) A61K 31/506 (2006.01) A61P 35/00 (2006.01) C07C 279/18 (2006.01)

Patent

CA 2529090

This application discloses compounds that inhibit Raf kinase having the formula (I), wherein R1 is a phenyl radical or a heteroaryl radical; and R2 is a phenyl radical; or an N-oxide or a pharmaceutically acceptable salt thereof. The compounds are useful for the treatment of proliferative diseases, such as cancer.

L'invention concerne des composés inhibant la Raf kinase représentés par la formule (I) ou un N-oxyde ou un sel pharmaceutiquement acceptable de celui-ci. Dans la formule (I), R¿1? représente un radical phényle ou un radical hétéroaryle; et R¿2? représente un radical phényle. On utilise ces composés pour traiter les maladies prolifératives, telles que le cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

2-aminopyrimidine derivatives as raf kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-aminopyrimidine derivatives as raf kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-aminopyrimidine derivatives as raf kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1672606

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.